US pharmacy chain CVS has announced a new program, RxZERO, which will provide diabetes medications with no co-pay. According to research by CVS, people with diabetes typically spend around $467 out-of-pocket for brand name prescriptions every year, with some (12%) spend up to $1,000 on diabetes medications. Read more